Roma CE / CME

Home About Contact Add Activities Provider Login

	Defining the therapeutic algorithm in patients with HR positive breast cancer - United States Target Audience The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer Learning Objectives Upon completion of this activity, participants should be better able to: Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall Apply the most recent evid... Relias LLC
	Antibody Drug Conjugates (ADC) - United States Target Audience The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer. Learning Objectives Upon completion of this activity, participants should be better able to: Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall Apply the most recent evi... Relias LLC

Defining the therapeutic algorithm in patients with HR positive breast cancer - United States

Target Audience The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer Learning Objectives Upon completion of this activity, participants should be better able to: Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall Apply the most recent evid...
Relias LLC

Antibody Drug Conjugates (ADC) - United States

Target Audience The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer. Learning Objectives Upon completion of this activity, participants should be better able to: Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall Apply the most recent evi...
Relias LLC

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map